1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Abicipar Pegol (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

Abicipar Pegol (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  • October 2014
  • -
  • GlobalData
  • -
  • 109 pages

Summary

Table of Contents

Search Inside

Abicipar Pegol (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

Summary

Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world. Currently the ME and AMD markets are dominated by the use of anti-VEGF monotherapy, however, in recent years, corticosteroid implants have been reaching the ME market which could challenge the stronghold these drugs have in this sector. The AMD market will see the arrival of the first therapies to treat dry AMD, fulfilling a huge unmet need in the management of this retinal disease, and these first-in-class therapies will strongly drive the market growth over the next ten years. The launch of wet AMD adjunctive therapies will also see a significant change in the treatment of AMD patients and have a positive impact on the market growth.

Allergan’s abicipar pegol is a novel, long-acting anti-VEGF drug that is based on the DARPin technology. It is undergoing clinical development as a potential treatment for patients with wAMD, and a Phase III clinical trial is expected to begin in Q2 2015.

Scope

- Overview of Macular Edema and Macular Degeneration, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Abicipar Pegol including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Abicipar Pegol for the top country from 2013 to 2023.
- Sales information covered for the US, France, Germany, Italy, Spain, UK and Japan

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for Macular Edema and Macular Degeneration.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of Abicipar Pegol performance.
- Obtain sales forecast for Abicipar Pegol from 2013-2023 in top 7 countries (the US, France, Germany, Italy, Spain, UK and Japan).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023

Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Age-related ...

Dry eye disease- Market Insights, Epidemiology and Market Forecast-2023

Dry eye disease- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dry eye disease - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Glaucoma  - Market Insights, Epidemiology and Market Forecast-2023

Glaucoma  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Glaucoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


Download Unlimited Documents from Trusted Public Sources

The future of the Ophthalmology Industry in the US

  • April 2017
    5 pages
  • Ophthalmology  

    Eye Disease  

  • United States  

    Canada  

    North America  

View report >

Cardiovascular Disease Statistics in the US

  • April 2017
    20 pages
  • Cardiovascular ...  

  • United States  

View report >

Ophthalmology Industry in the US

  • April 2017
    20 pages
  • Ophthalmology  

    Eye Disease  

  • United States  

View report >

Related Market Segments :

Eye Disease
Therapy
Ophthalmology

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.